These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30405927)

  • 1. Severe Hypocalcemia and Hypomagnesemia with Denosumab in Advanced Chronic Kidney Disease: Case Report and Literature Review.
    Marlow CF; Sharma S; Babar F; Lin J
    Case Rep Oncol Med; 2018; 2018():2059364. PubMed ID: 30405927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Recurrent Severe Hypocalcemia with Prolonged Hospitalization and Readmissions After Single Dose of Denosumab in Metastatic Prostate Cancer Patient.
    Kc O; Dahal PH; Koirala M; Kothagundla CS; Al Zaghal E; Fahed R
    J Community Hosp Intern Med Perspect; 2022; 12(2):60-64. PubMed ID: 35712685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Hypocalcemia and Dramatic Increase in Parathyroid Hormone after Denosumab in a Dialysis Patient: A Case Report and Review of the Literature.
    Bhanot RD; Kaur J; Bhat Z
    Case Rep Nephrol; 2019; 2019():3027419. PubMed ID: 31016056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Life-threatening sustained hypocalcemia following Denosumab use in metastatic prostate cancer.
    Patell K; Ajay K; Al Armashi AR; Bawwab A; Ravakhah K
    J Oncol Pharm Pract; 2022 Apr; 28(3):698-702. PubMed ID: 34693819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypocalcemia in a Patient With Metastatic Prostate Cancer From Denosumab Treatment.
    Gouli S; Wang J; Patel A; Allerton J
    Cureus; 2021 Aug; 13(8):e17046. PubMed ID: 34522524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypocalcemia post denosumab in patients with chronic kidney disease stage 4-5.
    Dave V; Chiang CY; Booth J; Mount PF
    Am J Nephrol; 2015; 41(2):129-37. PubMed ID: 25790847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid progression of vascular and soft tissue calcification while being managed for severe and persistent hypocalcemia induced by denosumab treatment in a patient with multiple myeloma and chronic kidney disease.
    Ueki K; Yamada S; Tsuchimoto A; Tokumoto M; Kumano T; Kitazono T; Tsuruya K
    Intern Med; 2015; 54(20):2637-42. PubMed ID: 26466702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SEVERE, PROLONGED, DENOSUMAB-INDUCED HYPOCALCEMIA WITH RECOVERY AFTER 111 DAYS OF HIGH-DOSE CALCIUM SUPPLEMENTATION.
    McCaleb RV; Johnson JT
    AACE Clin Case Rep; 2019; 5(1):e82-e85. PubMed ID: 31967007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe and prolonged hypocalcemia after a single dose of denosumab for metastatic breast cancer with diffuse bone involvement without prior calcium/vitamin D supplementations.
    Uhm SJ; Hall JA; Herrington JD
    J Oncol Pharm Pract; 2021 Jul; 27(5):1287-1290. PubMed ID: 33081580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypocalcaemia following denosumab in prostate cancer: A clinical review.
    Lau LH; Cliff ERS; Wong V; Wong H; Torkamani N; Eer A; Weickhardt A; Grossmann M
    Clin Endocrinol (Oxf); 2020 Jun; 92(6):495-502. PubMed ID: 32017154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer.
    Gartrell BA; Coleman RE; Fizazi K; Miller K; Saad F; Sternberg CN; Galsky MD
    Eur Urol; 2014 Feb; 65(2):278-86. PubMed ID: 23706567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Osteoporosis Care to Reduce Denosumab-Associated Hypocalcemia for Patients with Advanced Chronic Kidney Disease and End-Stage Renal Disease.
    Hsu CT; Deng YL; Chung MC; Tsai SF; Lin SY; Chen CH
    Healthcare (Basel); 2023 Jan; 11(3):. PubMed ID: 36766888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of hypocalcemia in patients receiving denosumab for prevention of skeletal-related events in bone metastasis.
    Yerram P; Kansagra S; Abdelghany O
    J Oncol Pharm Pract; 2017 Apr; 23(3):179-184. PubMed ID: 26830549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Analysis of Denosumab-Induced Hypocalcemia in Bone Metastasis Treatment: Renal Dysfunction Is Not a Risk Factor for Its Incidence in a Strict Denosumab Administration Management System with Calcium/Vitamin D Supplementation.
    Saito Y; Takekuma Y; Komatsu Y; Sugawara M
    Biol Pharm Bull; 2021; 44(12):1819-1823. PubMed ID: 34853264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency.
    Watkins KR; Rogers JE; Atkinson B
    Support Care Cancer; 2015 Jun; 23(6):1657-62. PubMed ID: 25421444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.
    Laskowski LK; Goldfarb DS; Howland MA; Kavcsak K; Lugassy DM; Smith SW
    J Med Toxicol; 2016 Sep; 12(3):305-8. PubMed ID: 26987988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Denosumab causing severe, refractory hypocalcaemia in a patient with chronic kidney disease.
    Saleem S; Patel S; Ahmed A; Saleem N
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29848528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Denosumab-Associated Severe Hypocalcemia in a Patient With Chronic Kidney Disease.
    Salim SA; Nair LR; Thomas L; Garla V; Palabindala V; Agarwal M; Fülöp T
    Am J Med Sci; 2018 May; 355(5):506-509. PubMed ID: 29753381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum ALP level is associated with increased risk of denosumab-related hypocalcemia in patients with bone metastases from solid tumors.
    Kinoshita Y; Arai M; Ito N; Takashi Y; Makita N; Nangaku M; Shinoda Y; Fukumoto S
    Endocr J; 2016 May; 63(5):479-84. PubMed ID: 26860123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion.
    Body JJ; von Moos R; Niepel D; Tombal B
    BMC Urol; 2018 Sep; 18(1):81. PubMed ID: 30236112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.